contents
Cardiovascular
41
PCSK9 inhibitors: hope or hype?
Heerajnarain Bulluck and Will Davies
47
The leadless pacemaker:
a new era in cardiac pacing
Seth Dockrill and Patrick Heck
53
Cardiac biomarkers:
the power of innovation
Damien Gruson
55
Preventing and treating VTE
in patients with renal insufficiency
Piet Habbel, Cecilia Bozzetti and
Hanno Riess
60
The importance of vascular access
device selection: a case study
Caroline Crowson (sponsored)
39
HHE 2018 | hospitalhealthcare.com